Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults
出版年份 2023 全文链接
标题
Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 22, Issue 1, Pages 1008-1021
出版商
Informa UK Limited
发表日期
2023-10-24
DOI
10.1080/14760584.2023.2273892
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pneumococcal vaccination coverage and adherence to recommended dosing schedules in adults: a repeated cross-sectional study of the INTEGO morbidity registry
- (2023) Arne Janssens et al. BMC PUBLIC HEALTH
- Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain
- (2023) David Cantarero et al. Vaccine
- Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine
- (2023) Estelle Méroc et al. Microorganisms
- Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
- (2023) Mikkelsen Malene B et al. Cost Effectiveness and Resource Allocation
- Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly
- (2022) Shu-ling Hoshi et al. VACCINE
- Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease
- (2022) Diana Mendes et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in Denmark compared with PPV23
- (2022) Jens Olsen et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-Effectiveness of Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine in the Italian Adult Population
- (2022) Barbara Polistena et al. Vaccines
- Belgian population norms for the EQ-5D-5L, 2018
- (2021) Lisa Van Wilder et al. QUALITY OF LIFE RESEARCH
- The impact of multimorbidity patterns on health-related quality of life in the general population: results of the Belgian Health Interview Survey
- (2021) Lisa Van Wilder et al. QUALITY OF LIFE RESEARCH
- Mortality and readmission in the year following hospitalization for pneumonia among US adults
- (2021) Ahuva Averin et al. RESPIRATORY MEDICINE
- Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis
- (2021) Hao Chen et al. Scientific Reports
- Pneumococcal vaccination prevented severe LRTIs in adults: a causal inference framework applied in registry data
- (2021) Pavlos Mamouris et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective
- (2020) Lieven Annemans et al. VALUE IN HEALTH
- Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations
- (2019) A. Løchen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pneumococcal Disease: A Systematic Review of Health Utilities, Resource Use, Costs, and Economic Evaluations of Interventions
- (2019) Tinevimbo Shiri et al. VALUE IN HEALTH
- Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design
- (2018) John M McLaughlin et al. CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection
- (2018) Sophie Marbaix et al. PLoS One
- Serotype-specific differences in short- and longer-term mortality following invasive pneumococcal disease
- (2016) G. J. HUGHES et al. EPIDEMIOLOGY AND INFECTION
- Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium
- (2015) Johan Flamaing et al. BMC Family Practice
- Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
- (2015) Marie-Josée J. Mangen et al. EUROPEAN RESPIRATORY JOURNAL
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
- (2015) Marc J.M. Bonten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community
- (2015) Bernhard Ultsch et al. PHARMACOECONOMICS
- The Intego database: background, methods and basic results of a Flemish general practice-based continuous morbidity registration project
- (2014) Carla Truyers et al. BMC Medical Informatics and Decision Making
- Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009–2011
- (2014) J Verhaegen et al. Eurosurveillance
- Pneumococcal pneumonia and the risk of acute coronary syndrome: A population-based cohort study
- (2013) Chun-Cheng Wang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England
- (2012) Albert Jan van Hoek et al. JOURNAL OF INFECTION
- A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
- (2010) Neil French et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and economic burden of community-acquired pneumonia among adults in Europe
- (2010) T Welte et al. THORAX
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now